Post by LymeEnigma on Sept 20, 2008 11:01:52 GMT -8
New Study Building off Viral Genetics' Research Aims to Unlock the Mysteries behind Lyme Disease and Other Immune Based Diseases Including HIV/AIDS
Gift from Undisclosed Source Will Go towards Study Which Researchers Hope Will Reconcile Long-Standing Debate over Treatment of Lyme Disease
Last update: 6:27 p.m. EDT Sept. 10, 2008
AZUSA, Calif., Sep 10, 2008 (BUSINESS WIRE) -- Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, announced today it has completed an initial study that aims to unlock the mysteries behind Lyme Disease, which could also potentially offer answers to other immune-based diseases including HIV/AIDS. In addition, a $25,000 gift has been awarded from an undisclosed source to further explore this new model in Lyme Disease through follow-on studies which researchers, including lead investigator Professor M. Karen Newell, PhD, Professor at the University of Colorado at Colorado Springs, hope will serve to reconcile the long-standing and controversial debate in the medical community over treatment methods for Lyme Disease.
Read the full article: www.marketwatch.com/news/story/new-study-building-off-viral/story.aspx?guid={55BC3F7C-350C-47FE-9B05-B243FEACF03E}&dist=hppr
Gift from Undisclosed Source Will Go towards Study Which Researchers Hope Will Reconcile Long-Standing Debate over Treatment of Lyme Disease
Last update: 6:27 p.m. EDT Sept. 10, 2008
AZUSA, Calif., Sep 10, 2008 (BUSINESS WIRE) -- Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, announced today it has completed an initial study that aims to unlock the mysteries behind Lyme Disease, which could also potentially offer answers to other immune-based diseases including HIV/AIDS. In addition, a $25,000 gift has been awarded from an undisclosed source to further explore this new model in Lyme Disease through follow-on studies which researchers, including lead investigator Professor M. Karen Newell, PhD, Professor at the University of Colorado at Colorado Springs, hope will serve to reconcile the long-standing and controversial debate in the medical community over treatment methods for Lyme Disease.
Read the full article: www.marketwatch.com/news/story/new-study-building-off-viral/story.aspx?guid={55BC3F7C-350C-47FE-9B05-B243FEACF03E}&dist=hppr